Impulse Dynamics Revenue and Competitors

Stuttgart, Germany

Location

$246.3M

Total Funding

Estimated Revenue & Valuation

  • Impulse Dynamics's estimated annual revenue is currently $110.3M per year.(i)
  • Impulse Dynamics's estimated revenue per employee is $351,400
  • Impulse Dynamics's total funding is $246.3M.

Employee Data

  • Impulse Dynamics has 314 Employees.(i)
  • Impulse Dynamics grew their employee count by -5% last year.

Impulse Dynamics's People

NameTitleEmail/Phone
1
VP, Regulatory AffairsReveal Email/Phone
2
VP, Regulatory Affairs and QualityReveal Email/Phone
3
VP Human ResourcesReveal Email/Phone
4
Chief Technology Officer and EVPReveal Email/Phone
5
Director, Healthcare EconomicsReveal Email/Phone
6
Director, Global Technical Operations & Product ManagementReveal Email/Phone
7
Territory ManagerReveal Email/Phone
8
Territory ManagerReveal Email/Phone
9
Sr. Clinical Trial ManagerReveal Email/Phone
10
Area Sales Director - North Central United StatesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$19.6M7811%N/AN/A
#2
$142.3M567-3%N/AN/A
#3
$8.5M340%N/AN/A
#4
$58.7M23438%N/AN/A
#5
$15.1M6011%N/AN/A
#6
$73.5M29328%N/AN/A
#7
$28.4M11314%N/AN/A
#8
$22.3M8935%N/AN/A
#9
$96.4M384N/AN/AN/A
#10
$24.1M964%N/AN/A
Add Company

What Is Impulse Dynamics?

Impulse Dynamics is dedicated to improving the lives of people with heart failure and is the developer of the innovative CCMᅢᄁ¬ダᅡᄁ therapy delivered by the Optimizerᅢツᅡᆴ system. CCM therapy is a breakthrough heart failure treatment that is proven to improve quality of life for heart failure patients. CCM therapy is specifically designed to improve systolic contraction in an effort to deliver more oxygen-rich blood to the body. It is a breakthrough, FDA-approved treatment that is proven to improve the quality of life for heart failure patients. CCM therapy is a safe and effective minimally invasive treatment option for millions of heart failure patients who otherwise have few effective options available to them Optimizer was granted Breakthrough Device designation by the FDA and is the first and only FDA-approved device in the U.S. or elsewhere for the delivery of CCM therapy.

keywords:N/A

$246.3M

Total Funding

314

Number of Employees

$110.3M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Impulse Dynamics News

2022-04-17 - Impulse Dynamics Announces 7000th Patient Treated With ...

Impulse Dynamics is steeped in a culture that celebrates making patients our top priority. From its very inception, the company has held fast to...

2022-04-17 - Carotid Artery Stents Market Size, Outlook And Forecast ...

... Medtronic, Johnson & Johnson, Terumo Corporation, MicroPort Scientific, Gore & Associates, BIOTRONIK, InspireMD, Impulse Dynamics.

2022-03-22 - Impulse Dynamics Announces First Patient Enrolled in AIM ...

The Optimizer delivers cardiac contractility modulation therapy — a proprietary technology of Impulse Dynamics — to the heart. Impulse Dynamics...

2021-01-12 - Impulse Dynamics Raises $60M in Series D Crossover Financing

Impulse Dynamics, a Marlton, N.J.-based company serving healthcare providers focused on people with heart failure, completed a $60m supplemental Series D crossover financing. Backers included new investors anchored by CR-CCT Industry Pilot Fund together with Redmile Group and Perceptive Advisor ...

2021-01-12 - Impulse Dynamics Closes $60 Million Financing

MARLTON, N.J.--(BUSINESS WIRE)--Impulse Dynamics, a company dedicated to helping healthcare providers improve the lives of people with heart failure, today announced the completion of a $60 million supplemental Series D crossover financing with new investors, anchored by CR-CCT Industry Pilot Fu ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$139.8M3395%N/A
#2
N/A3485%N/A
#3
$71.8M39621%N/A
#4
$71.8M39621%N/A
#5
$150.4M41523%N/A